drugset
drugset / Trial / NCT01801124

EXPAREL Infiltrated Into the TAP for Postoperative Analgesia in Unilateral Abdominal Hernia Repair

NCT01801124 ↗

Phase 4 Completed 13 enrolled Pacira Pharmaceuticals, Inc
NaSingle-groupOpen-labelTreatment

Summary

Phase 4 study evaluating the effectiveness of EXPAREL when infiltrated into the the Transversus Abdominis Plane (TAP).

Timeline

Start
2012-04
Primary completion
2012-12
Completion
2012-12

Drugs

EvaluationDrugModalityDoseRoute
Subject Bupivacaine Other / unclassified 266 mg —

Indications

No indication recorded.